Synlett 2018; 29(15): 2056-2060
DOI: 10.1055/s-0037-1610655
letter
© Georg Thieme Verlag Stuttgart · New York

Ligand-Free CuI-Catalyzed Chemoselective S-Arylation of 2-Mercaptobenzimidazole with Aryl Iodides

Bryan Yong-Hao Tan
,
Yong-Chua Teo*
Natural Sciences and Science Education, National Institute of Education, Nanyang Technological University, 1 Nanyang Walk, Singapore 637616, Singapore   Email: yongchua.teo@nie.edu.sg
› Author Affiliations
We would like to thank Nanyang Technological University (RP 5/13 TYC) for funding this work.
Further Information

Publication History

Received: 25 April 2018

Accepted after revision: 16 July 2018

Publication Date:
27 August 2018 (online)


Abstract

A practical and efficient strategy for the chemoselective C–S cross-coupling of 2-mercaptobenzimidazole derivatives with a range of substituted aryl iodides is described. Under the optimized conditions of 5 mol% CuI and 100 °C, a variety of S-arylated products were obtained in good to excellent yields (up to 92 %) without the need for assisting ligands.

Supporting Information

 
  • References and Notes

  • 1 Kondo T. Mitsudo T. Chem. Rev. 2000; 100: 3205
  • 2 Fernández-Rodríguez MA. Hartwig JF. Chemistry 2010; 16: 2355
  • 3 Fernández-Rodríguez MA. Shen Q. Hartwig JF. J. Am. Chem. Soc. 2006; 128: 2180
  • 4 Schwab RS. Singh D. Alberto EE. Piquini P. Rodrigues OE. Braga AL. Catal. Sci. Technol. 2011; 1: 569
  • 5 Migita T. Shimizu T. Asami Y. Shiobara J.-I. Kato Y. Kosugi M. Bull. Chem. Soc. Jpn. 1980; 53: 1385
  • 6 Jammi S. Barua P. Rout L. Saha P. Punniyamurthy T. Tetrahedron Lett. 2008; 49: 1484
  • 7 Xu X.-B. Liu J. Zhang J.-J. Wang Y.-W. Peng Y. Org. Lett. 2013; 15: 550
  • 8 Zhang Y. Ngeow KC. Ying JY. Org. Lett. 2007; 9: 3495
  • 9 Zheng N. McWilliams JC. Fleitz FJ. Armstrong JD. Volante RP. J. Org. Chem. 1998; 63: 9606
  • 10 Correa A. Carril M. Bolm C. Angew. Chem. Int. Ed. 2008; 47: 2880
  • 11 Feng Y. Wang H. Sun F. Li Y. Fu X. Jin K. Tetrahedron 2009; 65: 9737
  • 12 Herrero MT. SanMartin R. Domínguez E. Tetrahedron 2009; 65: 1500
  • 13 Li Y. Li X. Wang H. Chen T. Xie Y. Synthesis 2010; 3602
  • 14 Xu H.-J. Zhao X.-Y. Deng J. Fu Y. Feng Y.-S. Tetrahedron Lett. 2009; 50: 434
  • 15 Zhang X.-Y. Zhang X.-Y. Guo S.-R. J. Sulfur Chem. 2011; 32: 23
  • 16 Ferrini PG. Goschke R. US4632930, 1984
  • 17 Gilman NW. Chen WY. US4973599, 1990
  • 18 Chimirri A. Grasso S. Molica C. Monforte A. Monforte P. Zappalà M. Bruno G. Nicolò F. Witvrouw M. Jonckeere H. Antivir. Chem. Chemother. 1997; 8: 363
  • 19 Buckheit RW. Hollingshead MG. Germany-Decker J. White EL. McMahon JB. Allen LB. Ross LJ. Decker WD. Westbrook L. Shannon WM. Antivir. Res. 1993; 21: 247
  • 20 De Palma AM. Heggermont W. Lanke K. Coutard B. Bergmann M. Monforte A.-M. Canard B. De Clercq E. Chimirri A. Pürstinger G. J. Virol. 2008; 82: 4720
  • 21 Jung EJ. Hur M. Kim YL. Lee GH. Kim J. Kim I. Lee M. Han H.-K. Kim M.-S. Hwang S. J. Pharmacol. Exp. Ther. 2009; 331: 1005
  • 22 Bennamane N. Zaïoua K. Akacem Y. Kaoua R. Bentarzi Y. Bakhta S. Nedjar-Kolli B. Ouhab L. Org. Commun. 2009; 2
  • 23 Carcanague D. Shue Y.-K. Wuonola MA. Uria-Nickelsen M. Joubran C. Abedi JK. Jones J. Kühler TC. J. Med. Chem. 2002; 45: 4300
  • 24 de Assis JV. Couri MR. C. Porto RS. de Almeida WB. dos Santos LH. R. Diniz R. de Almeida MV. J. Heterocycl. Chem. 2013; 50: E142
  • 25 Katritzky AR. Akutagawa K. J. Org. Chem. 1989; 54: 2949
  • 26 Sperotto E. van Klink GP. van Koten G. de Vries JG. Dalton Trans. 2010; 39: 10338
  • 27 Kunz K. Scholz U. Ganzer D. Synlett 2003; 2428
  • 28 Larsson P.-F. Correa A. Carril M. Norrby P.-O. Bolm C. Angew. Chem. Int. Ed. 2009; 48: 5691
  • 29 Wolter M. Nordmann G. Job GE. Buchwald SL. Org. Lett. 2002; 4: 973
  • 30 Maiti D. Buchwald SL. J. Org. Chem. 2010; 75: 1791
  • 31 Antilla JC. Klapars A. Buchwald SL. J. Am. Chem. Soc. 2002; 124: 11684
  • 32 Sekar R. Srinivasan M. Marcelis AT. Sambandam A. Tetrahedron Lett. 2011; 52: 3347
  • 33 Tan BY.-H. Teo Y.-C. Tetrahedron 2016; 72: 6646
  • 34 Tan BY.-H. Teo Y.-C. Synlett 2016; 27: 1814
  • 35 Yong F.-F. Teo Y.-C. Chua G.-L. Lim GS. Lin Y. Tetrahedron Lett. 2011; 52: 1169
  • 36 Yong F.-F. Teo Y.-C. Synlett 2010; 3068
  • 37 Tan BY.-H. Teo Y.-C. Seow A.-H. Eur. J. Org. Chem. 2014; 7: 1541
  • 38 Klapars A. Huang X. Buchwald SL. J. Am. Chem. Soc. 2002; 124: 7421
  • 39 Klapars A. Antilla JC. Huang X. Buchwald SL. J. Am. Chem. Soc. 2001; 123: 7727
  • 40 General Procedure for S-Arylation of 2-Mercaptobenzimidazoles A mixture of CuI (Sigma-Aldrich, 0.025 mmol, 5 mol%), anhydrous K3PO4 (0.65 mmol), 2-mercaptobenzimidazole (0.5 mmol), DMSO (0.2 mL), and aryl halide (0.75 mmol) were added to a reaction vial and a screw cap was fitted to it. The reaction mixture was stirred under air in a closed system at 100 °C for 24 h. The heterogeneous mixture was subsequently cooled to room temperature and diluted with dichloromethane. The combined organic extracts were dried with anhydrous Na2SO4, and the solvent was removed under reduced pressure. The crude product was loaded into the column using minimal amounts of dichloromethane and was purified by silica gel column chromatography to afford the S-arylated product. The identity and purity of products was confirmed by 1H NMR and 13C NMR spectroscopic analysis. 2-(Phenylthio)-1H-benzo[d]imidazole (2aa) 101 mg (90% yield) of the coupled product was obtained as an off-white solid. 1H NMR (400 MHz, DMSO-d): δ = 12.50 (br s, 1 H), 7.62 (dd, J = 25.6, 7.6 Hz, 2 H), 7.42–7.31 (m, 7 H). 13C NMR (100 MHz, DMSO-d): δ = 147.6, 135.4, 131.3, 130.1, 129.6, 122.8, 118.7, 110.4. HRMS: m/z calcd [M+]: 227.0641; found: 227.0644. 2-[(2-Fluorophenyl)thio]-1H-benzo[d]imidazole (2ab) 105 mg (86% yield) of the coupled product was obtained as an off-white solid. 1H NMR (400 MHz, DMSO-d): δ = 12.77 (br s, 1 H), 7.58–7.48 (m, 3 H), 7.42–7.35 (m, 2 H), 7.28 (t, J = 5.6 Hz, 1 H), 7.16 (m, 2 H). 13C NMR (100 MHz, DMSO-d): δ = 160.8 (d, J = 240.0 Hz), 144.7 (d, J = 220.0 Hz), 134.7, 131.4 (d, J = 3.0 Hz), 125.5 (d, J = 3.0 Hz), 122.4, 119.8 (d, J = 340.0 Hz), 116.4, 116.2, 110.9. HRMS: m/z calcd [M+]: 245.0546; found: 245.0547. 2-[(2-Chlorophenyl)thio]-1H-benzo[d]imidazole (2ac) 114 mg (88% yield) of the coupled product was obtained as an off-white solid. 1H NMR (400 MHz, DMSO-d): δ = 12.96 (br s, 1 H), 7.60 (dd, J = 7.6, 1.6 Hz, 3 H), 7.40–7.29 (m, 3 H), 7.21 (s, 2 H). 13C NMR (100 MHz, DMSO-d): δ = 144.4, 133.1, 131.9, 131.3, 130.0, 129.4, 128.2, 122.7, 118.5, 111.3. HRMS: m/z calcd [M+]: 261.0251; found: 261.0249. 2-[(2-Methoxyphenyl)thio]-1H-benzo[d]imidazole (2ad) 106 mg (83% yield) of the coupled product was obtained as an off-white solid. 1H NMR (400 MHz, DMSO-d): δ = 12.64 (br s, 1 H), 7.49 (s, 2 H), 7.36 (t, J = 7.6 Hz, 2 H), 7.24–7.11 (m, 3 H), 6.96 (t, J = 7.6 Hz, 1 H), 3.82 (s, 3 H). 13C NMR (100 MHz, DMSO-d): δ = 157.1, 146.3, 131.8, 129.7, 121.9, 121.3, 119.3, 111.9, 106.1, 56.0. HRMS: m/z calcd [M+]: 257.0746; found: 257.0743.